Skip to main content
Drug Safety Reporting
Contact Us
Login
enquiry@zuventus.com
Email Us
+91 22 35060000
Make a call
About Us
Overview
Our Group
Milestones
Awards & Recognitions
Global Presence
Logistic Power and Reach
Manufacturing
Quality
CSR
Core Values
Corporate Presentation & Logo
People
Board of Directors
Leadership team
R&D
R&D capability
Products
Leading Products
New Launches
Product Finder
Patients & Caregivers
Healthcare Professionals (HCPs)
Research Publications
Newsroom
News & PR
Upcoming products
Latest Launches
Events / Webinars
Upcoming Webinars
Past Webinars
Compliance
Policies
Whistle Blower Policy
Nomination & Remuneration Policy
Terms and conditions of appointment of independent directors
POSH Policy
Pricing
NLEM Prices
Corporate Governance
Annual Returns
AGM NOTICE
EGM Notice
Other Disclosure
Statutory Compliance
Life @ Zuventus
Work with Us
Campus Connect
Internship Programme
Management Trainee Program
Fun @ Zuventus
Annual Day
Celebration
Sports
Learning & Development
Search
Search
Home
References
Zustpen Injection
Biapenem Against Drug Resistant Mycobacterium Tuberculosis
Download
Biapenem vs Meropenem
Download
We'd love to get to know you better! Could you please share a few details with us before we move forward?
I agree and authorize team to contact me. This will override the registry with DNC / NDNC. I consent to the processing of my personal data according to
Privacy Policy
&
T&C
Submit
Home
Monographs
Zustpen Injection
Zustpen Product Monograph
Download
We'd love to get to know you better! Could you please share a few details with us before we move forward?
I agree and authorize team to contact me. This will override the registry with DNC / NDNC. I consent to the processing of my personal data according to
Privacy Policy
&
T&C
Submit
Home
Videos
ZU-C 500
We'd love to get to know you better! Could you please share a few details with us before we move forward?
I agree and authorize team to contact me. This will override the registry with DNC / NDNC. I consent to the processing of my personal data according to
Privacy Policy
&
T&C
Submit
Home
Guidelines
Zutig 50 Injection
ICMR Treatment Guidelines 2019 Final
Download
IDSA 2023 Guidelines on Treatment of Resistant Gm-ve Infections
Download
We'd love to get to know you better! Could you please share a few details with us before we move forward?
I agree and authorize team to contact me. This will override the registry with DNC / NDNC. I consent to the processing of my personal data according to
Privacy Policy
&
T&C
Submit
Home
References
Zutig 50 Injection
Review of tigecycline
Download
Successful treatment of septic shock due to pan-resistant
Download
Tigecycline The answer to beta-lactam
Download
Tigecycline therapy for infections due to carbapenemase-producing
Download
Tigecycline an overview and update
Download
We'd love to get to know you better! Could you please share a few details with us before we move forward?
I agree and authorize team to contact me. This will override the registry with DNC / NDNC. I consent to the processing of my personal data according to
Privacy Policy
&
T&C
Submit
Home
Monographs
Zutig 50 Injection
Zutig Product Monograph
Download
We'd love to get to know you better! Could you please share a few details with us before we move forward?
I agree and authorize team to contact me. This will override the registry with DNC / NDNC. I consent to the processing of my personal data according to
Privacy Policy
&
T&C
Submit
Home
Videos
Zuviston Tablets
We'd love to get to know you better! Could you please share a few details with us before we move forward?
I agree and authorize team to contact me. This will override the registry with DNC / NDNC. I consent to the processing of my personal data according to
Privacy Policy
&
T&C
Submit
Home
Guidelines
Zostum 500 mg Injection
ICMR Treatment Guidelines 2019 Final
Download
We'd love to get to know you better! Could you please share a few details with us before we move forward?
I agree and authorize team to contact me. This will override the registry with DNC / NDNC. I consent to the processing of my personal data according to
Privacy Policy
&
T&C
Submit
Home
CME Slides
Zuviston Tablets
Atosiban - Updated slides
Download
AUB-O and dydrogesterone
Download
Dydrogesterone
Download
Dydrogesterone-Luteal Phase Support
Download
CPZ-SLB Vs IMI-TAZO in A.baumanni indused Bacteremia
Download
Gyn Loop slides.pps
Download
Management of RPL Current concepts
Download
Modern management of Endometriosis
Download
Ovulation induction
Download
PEGCLEAR 3350 CME slides
Download
Threatened Abortion
Download
We'd love to get to know you better! Could you please share a few details with us before we move forward?
I agree and authorize team to contact me. This will override the registry with DNC / NDNC. I consent to the processing of my personal data according to
Privacy Policy
&
T&C
Submit
Home
References
Zostum 500 mg Injection
30 % Mortality Rate Due to Anaerobic Infections
Download
38 Years of Unchanged Efficacy against ESKAPE and Ananerobes
Download
70% Infectiuons are caused by Biofilm Producing pathogens and CPZ-SLB is most effective against biofilm producing pathogenss
Download
CPZ Vs PIP-TAZO (70% Vs 60%) in Pneumonia
Download
CPZ Vs Pipera- TAZO against CAP
Download
CPZ-SLB Best Antibiotic for Surgical Prophylaxis (80% reduction in chances of Post Surgical Infections)
Download
CPZ-SLB in A.baumanii associated HAP
Download
CPZ SLB in Bacteremia
Download
CPZ SLB IN Febrile Neutropenia
Download
CPZ SLB in IAI and SSTI
Download
CPZ-SLB is the most Effective Antibiotic in Polymicrobial DFI
Download
CPZ-SLB offers 100% Efficacy in Obs & Gyn Infections
Download
CPZ-SLB Preferred Choice for SSI
Download
CPZ-SLB Results in 30 percentage Mortality reduction in Patients with VAP
Download
CPZ-SLB Results in 30 percentage Mortality reduction in Patients with VAP
Download
CPZ-SLB Vs IMI-TAZO in A.baumanni indused Bacteremia
Download
CPZ-SLB Vs PIP-TAZO IN RTI
Download
Excellent Susceptibility of CPZ-SLB against Bacterial Infections in Fractures
Download
ICMR Treatment Guidelines 2019 Final
Download
Polymicrobial infections creating difficulty in selecting empiric therapy
Download
Safety Of CPZ-SLB in Neonates Day 3 Onwards
Download
Susceptibility of CPZ-SLB Against Various Pthogens
Download
Unsuccessful Empiric Therapy is due to resistance amongst Ananerobes
Download
We'd love to get to know you better! Could you please share a few details with us before we move forward?
I agree and authorize team to contact me. This will override the registry with DNC / NDNC. I consent to the processing of my personal data according to
Privacy Policy
&
T&C
Submit
Pagination
« First
First page
‹ Previous
Previous page
…
27
28
29
30
31
32
33
34
35
…
Next ›
Next page
Last »
Last page
Subscribe to
